Roche Cuts Drug Prices in India – The Wall Street Journal.

I thought you would be interested in the following story on WSJ.com.

Roche Cuts Drug Prices in India

http://online.wsj.com/article/SB10001424052702303812904577297673910205972.html

Roche Holding AG is cutting the price of two expensive cancer drugs in India—and giving them new names—in an effort to gain market share and avoid competition from generic drugs in the fast-growing economy.

The move marks a shift for the Swiss drug maker, which long has argued that consumers everywhere should pay the same price for its medications. By giving the drugs new names in India, Roche hopes to avoid losing pricing power elsewhere, though it isn’t clear the company will succeed on that score.